Cambridge Investment Research Advisors, Inc. Merus N.V. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Merus N.V. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 12,285 shares of MRUS stock, worth $580,343. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,285
Previous 11,747
4.58%
Holding current value
$580,343
Previous $587,000
11.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$197 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$183 Million16.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$140 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$126 Million1.81% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$100 Million1.3% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.17B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...